0001001250-22-000219.txt : 20221123 0001001250-22-000219.hdr.sgml : 20221123 20221123115900 ACCESSION NUMBER: 0001001250-22-000219 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20221118 FILED AS OF DATE: 20221123 DATE AS OF CHANGE: 20221123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: de la Faverie Stephane CENTRAL INDEX KEY: 0001955038 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14064 FILM NUMBER: 221414512 MAIL ADDRESS: STREET 1: C/O THE ESTEE LAUDER COMPANIES INC. CITY: NEW YORK STATE: NY ZIP: 10153 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ESTEE LAUDER COMPANIES INC CENTRAL INDEX KEY: 0001001250 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 112408943 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 767 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10153 BUSINESS PHONE: 2125724200 MAIL ADDRESS: STREET 1: 767 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10153 3 1 wf-form3_166922272185844.xml FORM 3 X0206 3 2022-11-18 0 0001001250 ESTEE LAUDER COMPANIES INC EL 0001955038 de la Faverie Stephane C/O THE ESTEE LAUDER COMPANIES INC. 767 FIFTH AVENUE NEW YORK NY 10153 0 1 0 0 Executive Group President Class A Common Stock 2662.2215 D Restricted Stock Units (Share Payout) 2023-11-01 2023-11-01 Class A Common Stock 871.0 D Restricted Stock Units (Share Payout) 2023-11-01 2023-11-01 Class A Common Stock 3440.0 D Restricted Stock Units (Share Payout) 2024-11-01 Class A Common Stock 1494.0 D Restricted Stock Units (Share Payout) 2024-11-01 2024-11-01 Class A Common Stock 5813.0 D Restricted Stock Units (Share Payout) 2025-11-03 Class A Common Stock 4914.0 D Stock Option (Right to Buy) 138.15 2028-09-04 Class A Common Stock 3455.0 D Stock Option (Right to Buy) 199.49 2029-09-03 Class A Common Stock 5832.0 D Stock Option (Right to Buy) 218.06 2030-09-03 Class A Common Stock 10660.0 D Stock Option (Right to Buy) 344.06 2031-09-02 Class A Common Stock 9108.0 D Stock Option (Right to Buy) 246.15 2032-09-06 Class A Common Stock 15363.0 D Restricted Stock Units ("RSUs") vest and are paid out in shares of Class A Common Stock on a one-to-one basis on the applicable vesting date. RSUs generally vest in three approximately equal installments unless otherwise indicated. Upon payout, shares will be withheld to cover statutory tax obligations. These RSUs, awarded to the Reporting Person prior to designation as a Section 16 Insider, are accompanied by dividend equivalent rights that will be payable at the time of the payout of the related shares. RSUs from annual grant dated September 3, 2020. Assuming continued employment, these RSUs will vest and be paid out as follows: 871 on November 1, 2023. Not applicable. RSUs from non-annual grant dated September 3, 2020. Assuming continued employment, these RSUs will vest and be paid out in a single installment on November 1, 2023. RSUs from annual grant dated September 2, 2021. Assuming continued employment, these RSUs will vest and be paid out as follows: 747 on November 1, 2023; and 747 on November 1, 2024. RSUs from non-annual grant dated September 2, 2021. Assuming continued employment, these RSUs will vest and be paid out in a single installment on November 1, 2024. RSUs from annual grant dated September 6, 2022. Assuming continued employment, these RSUs will vest and be paid out as follows: 1,638 on November 1, 2023; 1,638 on November 1, 2024; and 1,638 on November 3, 2025. Stock options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of: 3,455 shares exercisable from and after January 1, 2022. Stock options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of: 2,916 shares exercisable from and after January 1, 2022; and 2,916 shares exercisable from and after January 1, 2023. Stock options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of: 3,553 shares exercisable from and after January 1, 2022; 3,553 shares exercisable from and after January 1, 2023; and 3,554 shares exercisable from and after January 1, 2024. Stock options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of: 3,036 shares exercisable from and after January 1, 2023; 3,036 shares exercisable from and after January 1, 2024; and 3,036 shares exercisable from and after January 1, 2025. Stock options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of: 5,121 shares exercisable from and after January 1, 2024; 5,121 shares exercisable from and after January 1, 2025; and 5,121 shares exercisable from and after January 1, 2026. Stephane de la Faverie, by Maureen Sladek, attorney-in-fact 2022-11-23 EX-24 2 poa_faverie2022.htm POA

POWER OF ATTORNEY

Know all by these presents that the undersigned hereby constitutes and appoints each of Deirdre Stanley, Spencer G. Smul, Maureen Sladek, Camille Ranadive, Annalisa Loeffler, and Robin Cohen, signing individually, the undersigned's true and lawful attorney-in-fact to:

(1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

(2) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and or director of The Estee Lauder Companies Inc. (the "Company") or as a stockholder of the Company or as a trustee of a stockholder of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

(3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and

(4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with, or liabilities that may arise under, Section 16 of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this __th day of November, 2022.


/s/Stephane de la Faverie
Stephane de la Faverie